The Effect of GLM 002, an Oriental Medicine, on Blood Pressure and Plasma Lipids in Spontaneously Hypertensive Rats |
Yu Byung Soo
(Department of Chemistry, Natural Science College, Wonkwang University)
Kim Hee Seok (Department of Chemistry, Natural Science College, Wonkwang University) Keon In Sook (Department of Herbal Resources, Professional Graduate School of Oriental Medicine, Wonkwang University) Lee Cheol Han (Department of Herbal Resources, Professional Graduate School of Oriental Medicine, Wonkwang University) Baek Seung Hwa (Faculty of Life Science, Hanil University & Presbyterian theological Sminary) |
1 |
Early development of spontaneous glomerular lesion in Syrian hamsters of APA strain
/
|
2 |
Glomerular lipidosis in a Syrian hamster of the APA strain
/
|
3 |
Increased vascular formation of angiotensin II in one-kidney, one clip hypertension
/
|
4 |
A sensitive fluorimetric assay for serum angiotensin-converting enzyme
/
|
5 |
An improved fluorometric assay of rat serum and plasma converting enzyme
/
|
6 |
Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models
/
|
7 |
Morphometric analysis of hypertension induced hypertrophy of rat thoracic aorta
/
|
8 |
Antihypertensive and Natriuretic Effects of CGS 30440, a Dual Inhibitor of Angiotensin Converting Enzyme and Neutral Endopeptidese 24.11
/
|
9 |
Angiotensin II-Induced Renal Vasoconstriction in Genetic Hypertension
/
|
10 |
Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study
/
|
11 |
The impact of angiotensin converting enzyme inhibitors on the arterial wall
/
|
12 |
Local generation and release of angiotensin II in peripheral vascular tissue
/
|
13 |
/
|
14 |
/
|
15 |
Adrenergic facilitation by angiotensin: does it serve a physiological function?
/
|
16 |
Tissue renin-angiotensin systems in renal hypertension
/
|
17 |
Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase
/
|
18 |
Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
/
|
19 |
Start of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor
/
|
20 |
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
/
|